Now, with its new AI-generated arsenal of porosome-targeted peptides and small molecules, the company has expanded emphasis on indications like Parkinson’s disease, Huntington’s disease, and others, ...

INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...

President Donald Trump took a victory lap in his 2026 State of the Union speech, during which he touted the economy, took jabs at Democrats and only briefly touched on foreign affairs.

The president derided Democrats and said the United States was “winning.” In the Democratic response, Gov. Abigail Spanberger of Virginia accused the president of sowing fear.

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that the Japan Patent Office (JPO) has issued a notice of allowance for Patent Application No. 2021-577862 ...

The health secretary said the Food and Drug Administration would “act on” a request from a former F.D.A. commissioner to ...

Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene ...

Proteins long known to be essential for hearing have been hiding a talent: they also act as gatekeepers that shuffle fatty ...

President Donald Trump on Tuesday night will get his highest-profile opportunity to convince skeptical Americans that his ...

Health experts say the federal government now shares less public health data, even after Robert F Kennedy Jr. promised "radical transparency." ...